Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?
Authors
Keywords
Gastric cancer, Biomarkers, Prognostic, Predictive, Targeted therapy, Patient stratification
Journal
VIRCHOWS ARCHIV
Volume 464, Issue 3, Pages 367-378
Publisher
Springer Nature
Online
2014-02-01
DOI
10.1007/s00428-013-1533-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial
- (2013) M. A. Gordon et al. ANNALS OF ONCOLOGY
- KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre study
- (2013) N C T van Grieken et al. BRITISH JOURNAL OF CANCER
- FGFR2 Gene Amplification in Gastric Cancer Predicts Sensitivity to the Selective FGFR Inhibitor AZD4547
- (2013) L. Xie et al. CLINICAL CANCER RESEARCH
- Prognostic and Putative Predictive Biomarkers of Gastric Cancer for Personalized Medicine
- (2013) Viktoria S. Warneke et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis
- (2013) EUROPEAN JOURNAL OF CANCER
- Somatic Mutations and Deletions of the E-Cadherin Gene Predict Poor Survival of Patients With Gastric Cancer
- (2013) Giovanni Corso et al. JOURNAL OF CLINICAL ONCOLOGY
- Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
- (2013) Florian Lordick et al. LANCET ONCOLOGY
- Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trial
- (2012) A. F. C. Okines et al. ANNALS OF ONCOLOGY
- New Sentinel Node Mapping Technologies for Early Gastric Cancer
- (2012) Hiroya Takeuchi et al. ANNALS OF SURGICAL ONCOLOGY
- Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer
- (2012) Jing Shi et al. BMC CANCER
- Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum
- (2012) D H Yoon et al. BRITISH JOURNAL OF CANCER
- MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome
- (2012) H E Lee et al. BRITISH JOURNAL OF CANCER
- Selective PI3K inhibition by BKM120 and BEZ235 alone or in combination with chemotherapy in wild-type and mutated human gastrointestinal cancer cell lines
- (2012) Annett Mueller et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Current questions for the treatment of advanced gastric cancer
- (2012) A. Cervantes et al. CANCER TREATMENT REVIEWS
- Second-generation irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs): A better mousetrap? A review of the clinical evidence
- (2012) Sai-Hong Ignatius Ou CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Vital-dye enhanced fluorescence imaging of GI mucosa: metaplasia, neoplasia, inflammation
- (2012) Nadhi Thekkek et al. GASTROINTESTINAL ENDOSCOPY
- A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets
- (2012) Niantao Deng et al. GUT
- Fibroblast growth factor receptor 2 gene amplification status and its clinicopathologic significance in gastric carcinoma
- (2012) Eun-Jung Jung et al. HUMAN PATHOLOGY
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial
- (2012) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical trials in gastric cancer and the future
- (2012) André L. Mihaljevic et al. JOURNAL OF SURGICAL ONCOLOGY
- Detection of kinase amplifications in gastric cancer archives using fluorescence in situ hybridization
- (2012) Shin-ichiro Kiyose et al. PATHOLOGY INTERNATIONAL
- High-Throughput Mutation Profiling Identifies Frequent Somatic Mutations in Advanced Gastric Adenocarcinoma
- (2012) Jeeyun Lee et al. PLoS One
- A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma
- (2011) J. A. Chan et al. ANNALS OF ONCOLOGY
- Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
- (2011) Birgit Luber et al. BMC CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MET Expression and Amplification in Patients with Localized Gastric Cancer
- (2011) Y. Y. Janjigian et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Genetic Activation of theMETPathway and Prognosis of Patients With High-Risk, Radically Resected Gastric Cancer
- (2011) Francesco Graziano et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic or Predictive? It's Time to Get Back to Definitions!
- (2011) Antoine Italiano JOURNAL OF CLINICAL ONCOLOGY
- METAmplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib
- (2011) Jochen K. Lennerz et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2011) Atsushi Ohtsu et al. JOURNAL OF CLINICAL ONCOLOGY
- EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study
- (2011) Robert Pirker et al. LANCET ONCOLOGY
- Personalized Colon Cancer Care in 2010
- (2011) Daniel V.T. Catenacci et al. SEMINARS IN ONCOLOGY
- Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study
- (2010) M. Moehler et al. ANNALS OF ONCOLOGY
- Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer
- (2010) Da-zhi Xu et al. BMC CANCER
- Oncogenic mutations in gastric cancer with microsatellite instability
- (2010) Giovanni Corso et al. EUROPEAN JOURNAL OF CANCER
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Efficacy of RAD001 (everolimus) against advanced gastric cancer with peritoneal dissemination
- (2010) Fumiko Taguchi et al. INVESTIGATIONAL NEW DRUGS
- Epirubicin, Oxaliplatin, and Capecitabine With or Without Panitumumab for Advanced Esophagogastric Cancer: Dose-Finding Study for the Prospective Multicenter, Randomized, Phase II/III REAL-3 Trial
- (2010) Alicia F.C. Okines et al. JOURNAL OF CLINICAL ONCOLOGY
- The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type
- (2010) Stefano Barbi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Hereditary gastric cancer
- (2009) Carla Oliveira et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer
- (2009) S-W Han et al. BRITISH JOURNAL OF CANCER
- Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients
- (2009) J D Barros-Silva et al. BRITISH JOURNAL OF CANCER
- Overexpression of Phosphorylated Mammalian Target of Rapamycin Predicts Lymph Node Metastasis and Prognosis of Chinese Patients with Gastric Cancer
- (2009) G. Yu et al. CLINICAL CANCER RESEARCH
- Germline CDH1 deletions in hereditary diffuse gastric cancer families
- (2009) C. Oliveira et al. HUMAN MOLECULAR GENETICS
- Validation of the Royal Marsden Hospital Prognostic Index in Advanced Esophagogastric Cancer Using Individual Patient Data From the REAL 2 Study
- (2009) Ian Chau et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
- (2008) C. Gravalos et al. ANNALS OF ONCOLOGY
- Assessment of a HER2 scoring system for gastric cancer: results from a validation study
- (2008) M Hofmann et al. HISTOPATHOLOGY
- EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number
- (2008) M A Kim et al. HISTOPATHOLOGY
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
- Screening for gastric cancer in Asia: current evidence and practice
- (2008) Wai K Leung et al. LANCET ONCOLOGY
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started